Key highlights

  • Global Health shares were down 10.00% at $0.045 during the 10 November 2026 trading session.
  • Operating cash outflow for the September 2026 quarter was $828,000, an improvement of $237,000 on the prior year quarter.
  • Operating cash outflow for the 12 months to September 2026 was $553,000, a reduction of 57%.

Global Health Ltd (ASX:GLH) traded lower during the 10 November 2026 trading session, with shares down 10.00% at $0.045. The S&P/ASX 200 was higher by 1.34%, or 121.20 points, at 9,150.90 over the same session. The Melbourne-based company earns Revenue from recurring licence subscriptions and implementation services. Its latest update was an Appendix 4C Cash Flow report and quarterly Business activity report for the quarter ended 30 September 2026, released on 26 October 2026.

Quarterly cash flow

Operating cash outflow improved by $237,000, or 22%, to $828,000 in the September 2026 quarter, from $1,065,000 in the September 2025 quarter. All figures are in Australian dollars and are subject to audit.

The company said sales and Marketing activity increases in the first half of the financial year, as prospects typically begin procurement in the first quarter. Cash collections are seasonally stronger in the December and June quarters and weaker in September and March.

Twelve-month trend

For the 12 months to September 2026, operating cash outflow was $553,000, a reduction of 57% or $738,000 on the prior twelve months. Group cash outflow for the same period was $296,000, down 71%.

Staff and contractor expenses over the 12 months fell by $739,000 compared with the previous year.

Sector context

Healthcare software companies with subscription revenue are often judged on whether cash use is falling and whether contracts convert into live deployments. Large projects typically go live between May and November, which can make quarterly results uneven. At 4.5 cents, Global Health trades in Penny Stock territory, and the broader market was higher during the session.

Risks

The company's cash flow remains negative on both a quarterly and a 12-month basis, so it depends on continued cost control and on new sales converting into revenue.

Deal timing is seasonal and large contracts are decided in specific quarters, so any delay could affect the pattern of cash receipts.

What to watch ahead

Investors will be looking at the December quarter cash flow report, which will include the period when major deals are typically decided, and any announcements on new contracts or go-live dates.

Final Word

Global Health's Trading session fall followed a Quarterly Report showing reduced operating cash outflow over the year. The company's sales results in the coming quarters will show whether that trend continues.